PROS1 and COVID-19: Furthermore, participants with one or more COVID‐19 vaccinations demonstrated significantly higher antibody responses against the S protein (98.0% vs. 97.0%, p = 0.042) and RBD (99.0% vs. 97.0%, p < 0.001) than the unvaccinated participants (Table 3).